structure of 3-Cyclopropyl-3-azabicyclo[3.3.1]nonan-9-one

3-Cyclopropyl-3-azabicyclo[3.3.1]nonan-9-one

CAS No.: 1000931-18-9
M. Wt: 179.26
M. Fa: C11H17NO
InChI Key: RJBDOXZFASAJEV-UHFFFAOYSA-N

Names and Identifiers of 1000931-18-9

CAS Number

1000931-18-9

EC Number

980-254-5

IUPAC Name

3-cyclopropyl-3-azabicyclo[3.3.1]nonan-9-one

InChI

InChI=1S/C11H17NO/c13-11-8-2-1-3-9(11)7-12(6-8)10-4-5-10/h8-10H,1-7H2

InChIKey

RJBDOXZFASAJEV-UHFFFAOYSA-N

Canonical SMILES

C1CC2CN(CC(C1)C2=O)C3CC3

Physical and chemical properties of 1000931-18-9

Acidity coefficient

8.14±0.20(Predicted)

Boiling Point

292.9±15.0 °C(Predicted)

Density

1.155±0.06 g/cm3(Predicted)

Molecular Formula

C11H17NO

Molecular Weight

179.26

Safety Information of 1000931-18-9

Pictograms

Signal Word

 Danger

Safety Data Sheet
Supports customized editing of SDS information and downloading in PDF documents.

Applications of 1000931-18-9

The applications of 3-cyclopropyl-3-azabicyclo[3.3.1]nonan-9-one span various fields:

  • Pharmaceuticals: Due to its potential neuroactive properties, it may serve as a lead compound in developing new medications for neurological disorders.
  • Biochemical Research: It is utilized in proteomics research as a biochemical tool for studying protein interactions and functions.

Interaction Studies of 1000931-18-9

Interaction studies involving 3-cyclopropyl-3-azabicyclo[3.3.1]nonan-9-one focus on its binding affinity with various receptors, particularly those associated with neurotransmission pathways. Preliminary studies suggest it may interact with acetylcholine receptors and other neurotransmitter systems, indicating potential roles in modulating synaptic activity.

Biological Activity of 1000931-18-9

Research indicates that 3-cyclopropyl-3-azabicyclo[3.3.1]nonan-9-one exhibits significant biological activity, particularly in neuropharmacology. Its structural similarity to known neurotransmitter systems suggests potential applications in modulating neurotransmission, potentially impacting conditions like anxiety and depression. Further studies are required to elucidate its specific mechanisms of action and therapeutic efficacy.